NASDAQ:KRMD - Repro Med Systems Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $8.17
  • Forecasted Upside: 170.42 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$3.02
▲ +0.17 (5.96%)
1 month | 3 months | 12 months
Get New Repro Med Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for KRMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for KRMD

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$8.17
▲ +170.42% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Repro Med Systems in the last 3 months. The average price target is $8.17, with a high forecast of $16.00 and a low forecast of $3.50. The average price target represents a 170.42% upside from the last price of $3.02.
Hold
The current consensus among 3 contributing investment analysts is to hold stock in Repro Med Systems.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/29/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/24/2021Canaccord GenuityReiterated RatingHold$5.00High
i
3/23/2021Piper SandlerLower Price TargetNeutral$4.50 ➝ $3.50High
i
1/26/2021Canaccord GenuityDowngradeBuy ➝ Hold$10.00 ➝ $5.00High
i
1/25/2021Piper SandlerDowngradeOverweight ➝ Neutral$9.00 ➝ $4.50High
i
11/5/2020Canaccord GenuityLower Price TargetBuy$13.00 ➝ $10.00Medium
i
Rating by Kyle Rose at Canaccord Genuity
8/14/2020Canaccord GenuityReiterated RatingBuy$13.00High
i
Rating by Kyle Rose at Canaccord Genuity
8/10/2020HC WainwrightInitiated CoverageBuy$16.00High
i
Rating by R. Selvaraju at HC Wainwright
8/6/2020Canaccord GenuityReiterated RatingBuy$13.00High
i
Rating by Kyle Rose at Canaccord Genuity
8/5/2020Piper SandlerBoost Price TargetOverweight$12.00 ➝ $14.00Low
i
Rating by Matthew O'Brien at Piper Sandler
7/16/2020Canaccord GenuityInitiated CoverageBuy$13.00Medium
i
6/24/2020Piper SandlerInitiated CoverageOverweight$12.00Medium
i
(Data available from 4/21/2016 forward)
Repro Med Systems logo
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Read More

Today's Range

Now: $3.02
$2.80
$3.06

50 Day Range

MA: $3.59
$2.85
$4.01

52 Week Range

Now: $3.02
$2.70
$12.84

Volume

218,325 shs

Average Volume

431,362 shs

Market Capitalization

$134.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.3

Frequently Asked Questions

What sell-side analysts currently cover shares of Repro Med Systems?

The following Wall Street research analysts have issued reports on Repro Med Systems in the last year: Canaccord Genuity, HC Wainwright, Piper Sandler, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for KRMD.

What is the current price target for Repro Med Systems?

3 Wall Street analysts have set twelve-month price targets for Repro Med Systems in the last year. Their average twelve-month price target is $8.17, suggesting a possible upside of 170.4%. HC Wainwright has the highest price target set, predicting KRMD will reach $16.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $3.50 for Repro Med Systems in the next year.
View the latest price targets for KRMD.

What is the current consensus analyst rating for Repro Med Systems?

Repro Med Systems currently has 2 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in KRMD, but not buy more shares or sell existing shares.
View the latest ratings for KRMD.

What other companies compete with Repro Med Systems?

How do I contact Repro Med Systems' investor relations team?

Repro Med Systems' physical mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The company's listed phone number is 845-469-2042 and its investor relations email address is [email protected] The official website for Repro Med Systems is www.korumedical.com.